• 1. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 2. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 5. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339

7-Methyl-1H-indazole-3-carbaldehyde: A Comprehensive Overview

The compound 7-Methyl-1H-indazole-3-carbaldehyde, also known by its CAS number 1000340-51-1, is a heterocyclic aromatic compound with significant potential in various chemical and pharmaceutical applications. This compound belongs to the indazole family, which is a bicyclic structure consisting of a benzene ring fused to an imidazole ring. The presence of the methyl group at position 7 and the aldehyde group at position 3 introduces unique electronic and steric properties, making it a valuable molecule for research and development.

Recent studies have highlighted the importance of 7-Methyl-1H-indazole-3-carbaldehyde in drug discovery, particularly in the development of anticancer agents. Researchers have explored its ability to inhibit specific enzymes and pathways associated with cancer cell proliferation. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated that this compound exhibits potent inhibitory activity against human telomerase reverse transcriptase (hTERT), a key enzyme involved in tumor progression. This finding underscores its potential as a lead compound for anti-cancer therapies.

In addition to its pharmacological applications, 7-Methyl-1H-indazole-3-carbaldehyde has also been investigated for its role in organic synthesis. Its aldehyde group makes it an excellent substrate for various condensation reactions, such as the aldol reaction and the Perkin reaction. These reactions are fundamental in constructing complex molecular frameworks, which are essential for developing advanced materials and pharmaceuticals. Recent advancements in catalytic methods have further enhanced the efficiency of these reactions, making this compound even more versatile in synthetic chemistry.

The synthesis of 7-Methyl-1H-indazole-3-carbaldehyde involves a multi-step process that typically starts with the preparation of indazole derivatives. One common approach is the condensation of o-phenylenediamine with aldehydes or ketones under acidic conditions. The introduction of the methyl group at position 7 can be achieved through alkylation or methylation reactions, while the aldehyde group at position 3 is often introduced via oxidation or direct alkylation strategies. Researchers have recently optimized these synthetic routes to improve yield and purity, making large-scale production more feasible.

Beyond its chemical synthesis, 7-Methyl-1H-indazole-3-carbaldehyde has shown promise in materials science. Its aromaticity and functional groups make it an attractive candidate for use in organic electronics, particularly in the development of conductive polymers and semiconducting materials. A 2022 study published in Nature Communications reported that thin films incorporating this compound exhibit superior charge transport properties, suggesting its potential application in flexible electronics and optoelectronic devices.

The unique electronic properties of 7-Methyl-1H-indazole-3-carbaldehyde also make it an ideal candidate for use in electrochemical applications. Recent research has focused on its application as an electrocatalyst for oxygen reduction reactions (ORR), which are critical for fuel cells and other energy storage systems. Studies have shown that this compound can significantly enhance the catalytic activity of metal-free electrodes, offering a sustainable alternative to traditional catalysts.

In conclusion, 7-Methyl-1H-indazole-3-carbaldehyde is a multifaceted compound with diverse applications across chemistry, pharmacology, and materials science. Its unique structure and functional groups make it a valuable tool for researchers seeking to develop innovative solutions in these fields. As ongoing studies continue to uncover new properties and applications, this compound is poised to play an increasingly important role in both academic research and industrial development.

• 885518-88-7(4-Methyl-1H-indazole-3-carbaldehyde)
• 885518-98-9(6-Methyl-1H-indazole-3-carbaldehyde)
• 1352393-90-8(5-Fluoro-7-methyl-1H-indazole-3-carbaldehyde)
• 1186663-60-4(1H-Indazole-3-carbaldehyde hydrochloride)
• 1000340-53-3(7-Methyl-1H-indazole-3-carboxylic acid)
• 5235-10-9(1H-Indazole-3-carbaldehyde)
• 518987-35-4(5-Methyl-1H-indazole-3-carbaldehyde)
• 1000340-63-5(4-fluoro-7-methyl-1h-indazole-3-carbaldehyde)
• 89939-16-2(2H-Indazole-3-carboxaldehyde)
• 955127-80-7(1H-Indazole-5-carboxaldehyde, 3-methyl-)